October 21, 2022

Balchem Announces Conference Call for Third Quarter 2022 Financial Results

Join Ted Harris, Chairman of the Board, CEO and President and Martin Bengtsson, CFO on Friday, November 4th at 11:00 AM Eastern Time (ET) to review 3rd Quarter 2022 results.
August 30, 2022

Balchem Corporation Acquires Bergstrom Nutrition

Balchem Corporation is excited to announce the acquisition of Cardinal Associates Inc., operating as “Bergstrom Nutrition,” a leading science-based manufacturer of methylsulfonylmethane (MSM), based in Vancouver, Washington.
July 15, 2022

Balchem Announces Conference Call for Second Quarter 2022 Financial Results

Join Ted Harris, Chairman of the Board, CEO and President and Martin Bengtsson, CFO on Friday, July 29th at 11:00 AM Eastern Time (ET) to review 2nd Quarter 2022 results.
June 21, 2022

Balchem Corporation Completes Acquisition of Kappa Bioscience AS

We are excited to announce that we completed our acquisition of Kappa Bioscience AS, a leading science-based manufacturer of specialty vitamin K2 for the human nutrition industry, headquartered in Oslo, Norway.
June 14, 2022

Balchem Corporation Signs Definitive Agreement to Acquire Kappa Bioscience AS

Balchem has signed a definitive agreement to acquire Kappa Bioscience AS, a leading science-based manufacturer of specialty vitamin K2 for the human nutrition industry, headquartered in Oslo, Norway.
April 22, 2022

Balchem Releases 2021 Sustainability Report

Balchem Corporation today released its 2021 Sustainability Report, which captures the Company's commitment to managing our Environmental, Social and Governance (ESG) performance.
April 15, 2022

Balchem Announces Conference Call for First Quarter 2022 Financial Results

Join Ted Harris, Chairman of the Board, CEO and President and Martin Bengtsson, CFO on Friday, April 29th at 11:00 AM Eastern Time (ET) to review 1st Quarter 2022 results.
February 4, 2022

Balchem Announces Conference Call for 4th Quarter 2021 Financial Results

Join Ted Harris, Chairman of the Board, CEO and President and Martin Bengtsson, CFO on Friday, February 18th at 11:00 AM Eastern Time (ET) to review 4th Quarter 2021 results.
October 29, 2021

Balchem Corporation Reports Third Quarter 2021 Financial Results

Ted Harris, Chairman, CEO, and President said, “Our performance this quarter reflects the strength of our global market positions as well as the resilience of our business model. We delivered record third quarter sales in all three of our reporting segments as well as record earnings while facing an extraordinarily difficult macro economic environment with global supply chain disruptions and input cost inflation.”
October 15, 2021

Balchem Announces Conference Call for 3rd Quarter 2021 Financial Results

Join Ted Harris, Chairman of the Board, CEO and President and Martin Bengtsson, CFO on Friday, October 29th at 11:00 AM Eastern Time (ET) to review 3rd Quarter 2021 results.
July 30, 2021

Balchem Corporation Reports Second Quarter 2021 Financial Results

Ted Harris, Chairman, CEO, and President of Balchem said, “The second quarter of 2021 was another strong quarter for Balchem. We delivered exceptional performance in a dynamic market environment and we continued to see strong demand for our products and services."
July 28, 2021

Balchem Corporation to Present at the Jefferies Virtual Industrials Conference on 8/4/2021

Join Ted Harris, CEO, and Martin Bengtsson, CFO to learn more about Balchem at the Jefferies Virtual Industrials Conference on 8/4/21.
1 2 3 7
Page 1 of 7